WSFS
LEGN icon

Wilmington Savings Fund Society’s Legend Biotech LEGN Stock Holding History

Wilmington Savings Fund Society’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27
Closed -$879 – 2116
2024
Q4 		$879 Buy
+27
New +$1.12K ﹤0.01% 2009

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wilmington Savings Fund Society's LEGN Position: Q1 2025 in Review

Wilmington Savings Fund Society sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 27 shares — an estimated $879 sold.

Wilmington Savings Fund Society first reported a position in LEGN in Q4 2024 and held it in 1 quarter. The position peaked at $879 in Q4 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Wilmington Savings Fund Society reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 27 Legend Biotech shares in Q1 2025, an estimated $879.
  • Wilmington Savings Fund Society first reported a position in Legend Biotech in Q4 2024 and held it in 1 quarter.
  • Wilmington Savings Fund Society's Legend Biotech position peaked at $879 in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2025, filed 8 May 2025.